A Study to Investigate the Efficacy and Safety of Cobimetinib Plus Atezolizumab in Participants With Solid Tumors

NCT03264066 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: Cobimetinib
DRUG: Atezolizumab
DRUG: Atezolizumab Cohort 7

Sponsor

Hoffmann-La Roche